The effect of physical barriers and properties on the oral absorption of particulates.

This paper provides an in-depth review of the biological, immunological, and physicochemical barriers to the oral absorption of microparticles. The roles of the mucus and mucosal cell layers are discussed along with technologies and strategies that may be used to improve uptake, including attempts to determine the mechanisms of microparticulate uptake into enterocytes and membranous epithelial (M) cells. Considerations unique to the absorption of microparticles, such as particle size, surface characteristics, cell surface interactions, and the driving force for absorption of microparticles, are also addressed. Although the extent of absorption of microparticles is severely limited, this review provides insight into potential methods and technologies that have been and could be used to improve the oral absorption of microparticles.

[1]  R. Irvin,et al.  Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. , 1992, The Journal of clinical investigation.

[2]  M. Steinhoff,et al.  Potential of polymer microencapsulation technology for vaccine innovation. , 1994, Vaccine.

[3]  L. Illum,et al.  In vivo evaluation of protein adsorption to sterically stabilised colloidal carriers. , 1993, Journal of biomedical materials research.

[4]  M. Skurnik,et al.  Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles , 1991, Infection and immunity.

[5]  J. Kreuter Nanoparticles and nanocapsules--new dosage forms in the nanometer size range. , 1978, Pharmaceutica acta Helvetiae.

[6]  G J Strous,et al.  Mucin-type glycoproteins. , 1992, Critical reviews in biochemistry and molecular biology.

[7]  W. Rubas,et al.  Mechanism of dextran transport across rabbit intestinal tissue and a human colon cell-line (CACO-2). , 1995, Journal of drug targeting.

[8]  R. Crowther,et al.  Counter‐ion binding to mucus glycoproteins , 1984, The Journal of pharmacy and pharmacology.

[9]  D. Winne,et al.  Diffusion coefficient in native mucus gel of rat small intestine , 1990, The Journal of pharmacy and pharmacology.

[10]  L. Lichtenberger The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.

[11]  M. Smith,et al.  Particle uptake and translocation across epithelial membranes. , 1996, Journal of anatomy.

[12]  M. Aprahamian,et al.  Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine , 1987, Biology of the cell.

[13]  T. Atkins,et al.  The incorporation and release of bovine serum albumin from poly(beta-hydroxybutyrate-hydroxyvalerate) microspheres. , 1996, Journal of biomaterials science. Polymer edition.

[14]  E. Grulke,et al.  Glass Transition Temperatures of Polymers , 1999 .

[15]  P. Vadgama,et al.  Electrochemical determination of the permeability of porcine mucus to model solute compounds , 1991, The Journal of pharmacy and pharmacology.

[16]  M C Davies,et al.  Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. , 1991, Biomaterials.

[17]  R. Erickson,et al.  Is the small intestinal epithelium truly "tight" to inulin permeation? , 1991, The American journal of physiology.

[18]  B. Hirst,et al.  Targeting to intestinal M cells. , 1996, Journal of anatomy.

[19]  J. Benoit,et al.  Intestinal absorption of PLAGA microspheres in the rat. , 1996, Journal of anatomy.

[20]  C. Migliaresi,et al.  A study on the in vitro degradation of poly(lactic acid). , 1994, Journal of biomaterials science. Polymer edition.

[21]  P. Vadgama,et al.  Estimation of effective diffusion coefficients of model solutes through gastric mucus: assessment of a diffusion chamber technique based on spectrophotometric analysis. , 1991, The Analyst.

[22]  T. Landsverk,et al.  Phagocytosis and transcytosis by the follicle‐associated epithelium of the ileal Peyer's patch in calves , 1988, Immunology and cell biology.

[23]  Sumie Yoshioka,et al.  Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate , 1991 .

[24]  A. Kondo,et al.  Immunological agglutination kinetics of latex particles with physically adsorbed antigens. , 1990, JIM - Journal of Immunological Methods.

[25]  K. C. Ting,et al.  Microparticles of poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery , 1997 .

[26]  B. Hirst,et al.  Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. , 1993, Journal of drug targeting.

[27]  S. Davis,et al.  The preparation and characterization ofpoly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein , 1994 .

[28]  G. Ponchel,et al.  Dynamic swelling behaviour of gelatin/poly(acrylic acid) bioadhesive microspheres loaded with oxprenolol. , 1997, Journal of microencapsulation.

[29]  R. Langer,et al.  Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. , 1997, Biomaterials.

[30]  M. Cooper,et al.  Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. , 1973, The American journal of anatomy.

[31]  Bradley S. Turner,et al.  Viscous fingering of HCI through gastric mucin , 1992, Nature.

[32]  M. Mantle,et al.  Adhesion of Yersinia enterocolitica to purified rabbit and human intestinal mucin , 1993, Infection and immunity.

[33]  S. Craig,et al.  PEYER'S PATCHES: AN ENRICHED SOURCE OF PRECURSORS FOR IGA-PRODUCING IMMUNOCYTES IN THE RABBIT , 1971, The Journal of experimental medicine.

[34]  N Hussain,et al.  Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. , 1995, Journal of drug targeting.

[35]  S. Nath,et al.  Quantification of protein transcytosis in the human colon carcinoma cell line CaCo‐2 , 1990, Journal of cellular physiology.

[36]  K. Ling,et al.  Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro. , 1989, The Journal of laboratory and clinical medicine.

[37]  A T Florence,et al.  Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. , 1994, Journal of drug targeting.

[38]  M. Mantle,et al.  Binding of Yersinia enterocolitica to purified, native small intestinal mucins from rabbits and humans involves interactions with the mucin carbohydrate moiety , 1994, Infection and immunity.

[39]  S. Davis,et al.  Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.

[40]  J. Lamont Mucus: The Front Line of Intestinal Mucosal Defense , 1992, Annals of the New York Academy of Sciences.

[41]  E. Morris,et al.  Mucus glycoprotein gels. Role of glycoprotein polymeric structure and carbohydrate side-chains in gel-formation. , 1988, Carbohydrate research.

[42]  H. Ayhan,et al.  Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties. , 1995, Journal of biomaterials science. Polymer edition.

[43]  A. Coppola,et al.  Influence of physico-chemical parameters on the release of hydrocortisone acetate from albumin microspheres , 1994 .

[44]  G. Volkheimer,et al.  The phenomenon of persorption. , 1968, Digestion.

[45]  A. Jones,et al.  Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. , 1974, Gastroenterology.

[46]  J. Wolf,et al.  The membranous epithelial (M) cell and the mucosal immune system. , 1984, Annual review of medicine.

[47]  Donald E. Chickering,et al.  Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.

[48]  D. Bockman,et al.  Light and electron microscopy of intestinal ferritin absorption. Observations in sensitized and nonsensitized hamsters (Mesocricetus auratus) , 1966 .

[49]  M. Levine,et al.  Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide). , 1993, Vaccine.

[50]  D. Hollander,et al.  Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs. , 1990, Gut.

[51]  A. Schindler,et al.  Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers , 1979 .

[52]  A. Allen,et al.  Gastroduodenal mucosal protection. , 1993, Physiological reviews.

[53]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[54]  J. Madara,et al.  Loosening tight junctions. Lessons from the intestine. , 1989, The Journal of clinical investigation.

[55]  J. Mcghee,et al.  Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus Toxoid a , 1994 .

[56]  J. Eldridge,et al.  Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. , 1989, Advances in experimental medicine and biology.

[57]  S. Davis,et al.  Targeting of colloidal particles to the bone marrow. , 1987, Life sciences.

[58]  R. Kinne,et al.  In vitro permeability of PBCA nanoparticles through porcine small intestine. , 1993, Journal of drug targeting.

[59]  D. Lewis,et al.  The transport of microspheres from the gastro‐intestinal tract to inflammatory air pouches in the rat , 1989, The Journal of pharmacy and pharmacology.

[60]  H. Cottier,et al.  Uptake by enterocytes and subsequent translocation to internal organs, eg, the thymus, of Percoll microspheres administered per os to suckling mice. , 1983, Journal of the Reticuloendothelial Society.

[61]  J. Mcghee,et al.  Biodegradable microspheres as a vaccine delivery system. , 1991, Molecular immunology.

[62]  D. Keljo,et al.  Quantitative determination of macromolecular transport rate across intestinal Peyer's patches. , 1983, The American journal of physiology.

[63]  Zhaohui Li,et al.  Wicking Technique for Determination of Pore Size in Ceramic Materials , 1994 .

[64]  S. Kerss,et al.  A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. , 1982, Clinical science.

[65]  A. Florence,et al.  Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate , 1995 .

[66]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[67]  D. Hollander,et al.  Crohn's disease--a permeability disorder of the tight junction? , 1988, Gut.

[68]  And,et al.  Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin , 1990, Infection and immunity.

[69]  L. Balant,et al.  Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles. , 1994, Journal of biomedical materials research.

[70]  T. Gray,et al.  Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes , 1994, FEBS letters.

[71]  T. Ma,et al.  PEG 400, a hydrophilic molecular probe for measuring intestinal permeability. , 1990, Gastroenterology.

[72]  A. Florence,et al.  The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat , 1996 .

[73]  L. Illum,et al.  Influence of block copolymers on the adsorption of plasma proteins to microspheres. , 1993, Biomaterials.

[74]  T. Arita,et al.  Interaction of tertiary amines and quaternary ammonium compounds with gastrointestinal mucin. , 1986, Journal of pharmacobio-dynamics.

[75]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[76]  S. Davis,et al.  Polymeric microspheres as drug carriers. , 1988, Biomaterials.

[77]  J. Kreuter Nanoparticles and microparticles for drug and vaccine delivery. , 1996, Journal of anatomy.

[78]  Z. Policova,et al.  Bacterial cell surface hydrophobicity properties in the mediation of in vitro adhesion by the rabbit enteric pathogen Escherichia coli strain RDEC-1. , 1989, The Journal of clinical investigation.

[79]  P. Artursson,et al.  Diffusion of drugs in native and purified gastrointestinal mucus. , 1997, Journal of pharmaceutical sciences.

[80]  E. Boedeker,et al.  Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli. , 1993, Vaccine.

[81]  Eldridge,et al.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies , 1991, Infection and immunity.

[82]  C. McGuinness,et al.  Early intestinal microparticle uptake in the rat. , 1996, Journal of anatomy.

[83]  M. Marsh,et al.  Endocytosis: what goes in and how? , 1992, Journal of cell science.

[84]  Y Ikada,et al.  Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. , 1988, Biomaterials.

[85]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[86]  Patrick J. Sinko,et al.  Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin , 1997 .

[87]  Y. Ikada,et al.  Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. , 1988, Journal of biomedical materials research.

[88]  T. Ma,et al.  Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine. , 1989, Gastroenterology.

[89]  R. Compans,et al.  Oral immunization with influenza virus in biodegradable microspheres. , 1993, The Journal of infectious diseases.

[90]  J. Bienenstock,et al.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. , 1979, Journal of immunology.

[91]  D. McCarthy,et al.  Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose , 1992 .

[92]  K. Carr,et al.  Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat. , 1996, Journal of anatomy.

[93]  M. Deierkauf,et al.  Effects of albumin on the phagocytosis of polysterene spherules by rabbit polymorphonuclear leucocytes , 1978, Journal of cellular physiology.

[94]  P. Artursson,et al.  Microparticles as potentially orally active immunological adjuvants. , 1989, Vaccine.

[95]  R. Müller,et al.  Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. , 1987, Biomaterials.

[96]  E. Morris,et al.  Mechanical characterization and properties of gastrointestinal mucus gel. , 1987, Biorheology.

[97]  A. Dayan,et al.  Translocation of particulates across the gut wall--a quantitative approach. , 1995, Journal of drug targeting.

[98]  O'Hagan Dt,et al.  THE INTESTINAL UPTAKE OF PARTICLES AND THE IMPLICATIONS FOR DRUG AND ANTIGEN DELIVERY , 1996 .